Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021256-26-000004

Chief Financial Officer acquired 7,730 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Setia Vishwas Chief Financial Officer 2026-02-05 Grant or award +7,730 395,549 D
Derivatives
Setia Vishwas Chief Financial Officer 2026-02-05 Grant or award · Employee Stock Option (right to buy) +31,395 31,395 D
Loading xslF345X05/form4-02092026_050210.xml…